Identification of Actionable Genomic Alterations Across Different Lymphoma Histologies Using a Comprehensive Next Generation Genomic Sequencing Clinical Assay

被引：0

作者：

Batlevi, Connie ^{[1
]}

Moskowitz, Craig H. ^{[1
]}

Zelenetz, Andrew D. ^{[1
]}

Horwitz, Steven M. ^{[1
]}

Palomba, Lia ^{[1
]}

Gerecitano, John F. ^{[1
]}

Copeland, Amanda R. M. ^{[1
]}

Hamlin, Paul ^{[1
]}

Matasar, Matthew J. ^{[1
]}

Sauter, Craig S. ^{[1
]}

Moskowitz, Alison J. ^{[1
]}

Noy, Ariela ^{[1
]}

Straus, David J. ^{[1
]}

Portlock, Carol S. ^{[1
]}

Mazzei, Colleen ^{[1
]}

Pichardo, Janine D. ^{[1
]}

Miller, Vincent ^{[2
]}

Stephens, Phil J. ^{[2
]}

He, Jie ^{[2
]}

Feldstein, Julie T. ^{[1
]}

Levine, Ross L. ^{[1
]}

Dogan, Ahmet ^{[1
]}

Younes, Anas ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Fdn Med Inc, Cambridge, MA USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Identification Of Actionable Genomic Alterations In Hematologic Malignancies By a Clinical Next Generation Sequencing-Based Assay
Lipson, Doron
Nahas, Michelle K.
Otto, Geoff A.
Yelensky, Roman
Abdel-Wahab, Omar
Wang, Kai
He, Jie
Intlekofer, Andrew M.
Rampal, Raajit K.
Brennan, Timothy A.
Knapp, Kristina M.
Brennan, Kristina W.
Young, Geneva
Donahue, Amy L.
Sanford, Eric M.
Greenbowe, Joel R.
Frampton, Garrett M.
Fichtenholtz, Alex
Young, Lauren E.
Erlich, Rachel L.
Parker, Alex
Klimstra, David
Dogan, Ahmet
Ross, Jeffrey S.
Armstrong, Scott A.
Stephens, Philip J.
van den Brink, Marcel R. M.
Miller, Vincent A.
Levine, Ross L.
BLOOD, 2013, 122 (21)
[2] Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Yi-Hua Jan
Kien Thiam Tan
Shu-Jen Chen
Timothy Tak Chun Yip
Cu tai Lu
Alfred King-yin Lam
British Journal of Cancer, 2022, 127 : 1304 - 1311
[3] Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
Jan, Yi-Hua
Tan, Kien Thiam
Chen, Shu-Jen
Yip, Timothy Tak Chun
Lu, Cu Tai
Lam, Alfred King-Yin
BRITISH JOURNAL OF CANCER, 2022, 127 (07) : 1304 - 1311
[4] Defining the Incidence and Clinical Impact of Genomic Alterations Across Different Histologic Types of Lymphoma Using a Clinically Validated Comprehensive Targeted Sequencing Assay
Batlevi, Connie
Rapaport, Franck
Intlekofer, Andrew M.
Reiner, Anne
Moskowitz, Craig H.
Horwitz, Steven M.
Zelenetz, Andrew D.
Palomba, Lia
Moskowitz, Alison J.
Gerecitano, John F.
Hamlin, Paul A., Jr.
Copeland, Amanda R.
Matasar, Matthew J.
Sauter, Craig S.
Kumar, Anita
Noy, Ariela
Straus, David J.
Portlock, Carol S.
Criscuolo, Frederick
He, Jie
Royston, Daniel
Balasubramanian, Sohail
Reznikovskaya, Yekaterina
Pichardo, Janine D.
Stephens, Phil
Miller, Vincent
Levine, Ross L.
Seshan, Venkatraman
Dogan, Ahmet
Younes, Anas
BLOOD, 2015, 126 (23)
[5] Comprehensive Genomic Profiling of Hematologic Malignancies by a Clinical Next Generation Sequencing-Based Assay
Ross, J. S.
Nahas, M.
Lipson, D.
Otto, G. A.
Yelensky, R.
Abdel-Wahab, O.
Wang, K.
He, J.
Intlekofer, A. M.
Rampal, R. K.
Brennan, K.
Young, G.
Donahue, A.
Frampton, G.
Young, L.
Klimstra, D.
Dogan, A.
Armstrong, S. A.
van den Brink, M. R. M.
Miller, V. A.
Stephens, P. J.
Levine, R. L.
LABORATORY INVESTIGATION, 2014, 94 : 375A - 375A
[6] Comprehensive Genomic Profiling of Hematologic Malignancies by a Clinical Next Generation Sequencing-Based Assay
Ross, J. S.
Nahas, M.
Lipson, D.
Otto, G. A.
Yelensky, R.
Abdel-Wahab, O.
Wang, K.
He, J.
Intlekofer, A. M.
Rampal, R. K.
Brennan, K.
Young, G.
Donahue, A.
Frampton, G.
Young, L.
Klimstra, D.
Dogan, A.
Armstrong, S. A.
van den Brink, M. R. M.
Miller, V. A.
Stephens, P. J.
Levine, R. L.
MODERN PATHOLOGY, 2014, 27 : 375A - 375A
[7] Clinical application of comprehensive next-generation sequencing-based genomic profiling for identification of actionable genomic alterations in pediatric solid tumors and hematolymphoid malignancies: The Foundation Medicine pediatric experience.
Hawryluk, Matthew J.
Wang, Kai
Chmielecki, Juliann
Ali, Siraj M.
Palmer, Gary A.
Downing, Sean
Curran, John
Garcia, Lazaro
White, Emily
Lipson, Doron
Yelensky, Roman
Stephens, Philip J.
Miller, Vincent A.
Ross, Jeffrey S.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[8] Genomic profiling using a clinical next generation sequencing (NGS) assay reveals genomic alterations to guide targeted therapy in advanced neuroblastoma patients
Ali, S.
Sanford, E. M.
Hawryluk, M. J.
Chmielecki, J.
Wang, K.
Palmer, G. A.
Palma, N. A.
Morosini, D.
Erlich, R.
Yelensky, R.
Lipson, D.
Ross, J. S.
Mosse, Y.
Stephens, P. J.
Maris, J. M.
Miller, V. A.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : 132 - 132
[9] Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies
Niu, G. G.
Al-Rohil, R. N.
Vanushkina, M.
Sheehan, C. E.
Nazeer, T.
DiCaprio, M.
Palmer, G.
Ali, S. M.
Morosini, D.
Miller, V. A.
Stephens, P. J.
Ross, J. S.
MODERN PATHOLOGY, 2014, 27 : 23A - 24A
[10] Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies
Niu, G. G.
Al-Rohil, R. N.
Vanushkina, M.
Sheehan, C. E.
Nazeer, T.
DiCaprio, M.
Palmer, G.
Ali, S. M.
Morosini, D.
Miller, V. A.
Stephens, P. J.
Ross, J. S.
LABORATORY INVESTIGATION, 2014, 94 : 23A - 24A

← 1 2 3 4 5 →